IVF denied as not FDA-approved for this use by Blue Cross Blue Shield?
Off-label use is widespread in medicine. If the literature and a recognised specialty-society guideline support the use, plans frequently approve on appeal — especially for cancer, cardiology, and rare disease.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What Blue Cross Blue Shield typically requires
Blue Cross Blue Shield's specific coverage criteria for IVF are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.
The Blue Cross Blue Shield angle on IVF
## Why BCBS Denied Your IVF as "Not FDA-Approved"
In vitro fertilization (IVF) is a procedural intervention rather than a drug, so the FDA does not issue an "approval" for IVF itself the way it does for medications. BCBS and its licensee plans sometimes apply a "not FDA-approved" denial code when their automated systems flag reproductive procedures that fall outside standard drug-approval classifications. This denial is frequently a coding or categorization error and is highly appealable.
## Why This Denial Is Appealable
IVF is a well-established, guideline-supported treatment for infertility recognized by major reproductive medicine organizations. When a plan applies a "not FDA-approved" standard to a surgical or procedural service, that standard is being applied incorrectly. Your appeal should document that IVF is a procedure — not an investigational drug — and that it is the standard of care for your diagnosed condition per your fertility specialist.
## Federal Appeal Framework
- Internal appeal: You have the right to a full internal review under ERISA §503 (if employer-sponsored) or applicable state law. Submit within the deadline on your denial notice — typically 180 days.
- External review: Under ACA §2719, if the internal appeal is denied, you may escalate to an independent external review organization (IRO). The IRO's decision is binding on the plan. You generally have four months from the final internal denial to request external review.
- Expedited review: If your treating physician certifies that waiting for the standard timeline poses a serious health risk, you may request an expedited determination (typically 72-hour turnaround).
## Documentation to Gather
- Diagnosis confirmation: Medical records confirming your infertility diagnosis with ICD code, duration, and clinical basis.
- Prior-treatment history: Dates and outcomes of all prior fertility treatments attempted, with clinical notes.
- Clinical severity: Physician notes documenting why IVF is medically indicated at this stage.
- Medical-necessity letter: A detailed letter from your reproductive endocrinologist explaining why IVF is the appropriate standard of care for your specific diagnosis.
- Plan document language: Pull the exact benefit language from your Summary Plan Description — if IVF is listed as a covered benefit, note that the "not FDA-approved" rationale contradicts your own plan's terms.
## Criteria-Mapping Structure
Obtain the full text of BCBS's applicable coverage/medical policy for infertility treatment. List each stated coverage requirement. For each requirement, pair it with the exact supporting fact from your medical record. Your physician's letter should address each criterion point by point, using language from the policy itself. If the denial reason conflicts with the benefit description in your plan documents, state that conflict explicitly in your appeal letter.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →Related appeal guides
- Blue Cross Blue Shield denied as not FDA-approved for this use of 17ohp Compounded
- Blue Cross Blue Shield denied as not FDA-approved for this use of AAT Augmentation
- Blue Cross Blue Shield denied as not FDA-approved for this use of Amphetamine Stimulant Prodrug
- Blue Cross Blue Shield denied as not FDA-approved for this use of Anti Cd 20 Ocrevus